Serge Saxonov - Dec 27, 2023 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact for Serge Saxonov
Stock symbol
TXG
Transactions as of
Dec 27, 2023
Transactions value $
$17,922
Form type
4
Date filed
12/29/2023, 04:17 PM
Previous filing
Dec 18, 2023
Next filing
Jan 18, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Options Exercise $17.9K +14.9K +1.77% $1.20* 860K Dec 27, 2023 Direct
holding TXG Class A Common Stock 27 Dec 27, 2023 See footnote F1
holding TXG Class A Common Stock 870 Dec 27, 2023 See footnote F2
holding TXG Class A Common Stock 183K Dec 27, 2023 See footnote F3
holding TXG Class A Common Stock 16.3K Dec 27, 2023 See footnote F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TXG Stock Option (right to buy) Options Exercise $0 -14.9K -15.82% $0.00 79.5K Dec 27, 2023 Class A Common Stock 14.9K $1.20 Direct F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.
F2 The shares are held by the Sirius Trust, for which the Reporting Person serves as trustee.
F3 The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.
F4 The shares are held by the Y/S Pot Trust, for which the Reporting Person serves as trustee.
F5 This option, originally for 300,000 shares, of which 220,537 have been exercised, vested as to 1/48th of the shares on October 1, 2017, and was fully vested as of October 1, 2021.
F6 The balance for this grant has been updated from the filing made on December 28, 2021 to reflect the correct amount.